The Pharmaceuticals and Medical Devices Agency (PMDA) has added a new project team titled “Project team for Consideration of Guiding Principles for AI Utilization.” This team is part of the agency’s “Projects Across Multi‑Offices” program and will focus on developing guiding principles for the use of artificial intelligence in pharmaceutical and medical device contexts.
Regulatorische Updates24. Aug. 2026•1 Min. Lesezeit
PMDA Adds Project Team for AI Utilization Guiding Principles
The Pharmaceuticals and Medical Devices Agency (PMDA) announced a new project team to develop guiding principles for AI utilization, listed under its “Projects Across Multi‑Offices” initiative.
Zusammengestellt vom PharmaCountry-Team · Quelle: Pharmaceuticals and Medical Devices Agency
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen